Beta
363108

Clinical and Epidemiological Profile of Mycetoma Foot: Observations from Eastern India

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Endemic medicine

Abstract

Background and Study Aim: Mycetoma, also known as Madura foot, is a chronic, progressive, granulomatous infection that affects the skin, subcutaneous tissue, and bone. It is typically caused by fungal or bacterial pathogens and is characterized by the formation of nodules, sinuses, and draining abscesses. Treatment of mycetoma often involves a combination of antifungal or antibacterial medications, surgical debridement of affected tissues, and long-term follow-up to prevent recurrence.The present study explored the cases of mycetoma foot in a tertiary care set-up in eastern India.
Patients and Methods: The study included diagnosed cases of mycetoma foot which were treated in the facility. Epidemiological data and detailed clinical data were noted in all cases. The discharging materials: purulent exudates with  grains (granules)  were sent for staining and culture to the microbiology department and microbiological data were noted. All patients were commenced on treatment as per the standard protocol.
Results: Our study noted 10 cases of mycetoma. The mean age of presentation was 38.4 years with male preponderance. Most of the cases affected right foot. On microbiological examination, gram-positive narrow filamentous branching bacilli were seen.  Surgical debridement was necessitated in all cases except one, and bone debridement was needed in three cases.
Conclusion: Delayed diagnosis or inadequate treatment can lead to severe deformities, disabilities, and even limb loss. Mycetoma foot requires multidisciplinary management involving dermatologists, infectious disease specialists, orthopaedic surgeons, and microbiologists for optimal outcomes.

DOI

10.21608/aeji.2024.279372.1368

Keywords

Mycetoma Foot, Microbiological examination, Antifungal medications

Authors

First Name

Rupak

Last Name

Chatterjee

MiddleName

-

Affiliation

Department of Medicine, Bijoygarh State General Hospital, Jadavpur, Kolkata, West Bengal, India

Email

rupakchatterjee95@gmail.com

City

-

Orcid

-

First Name

Ipsita

Last Name

Pramanik

MiddleName

-

Affiliation

Independent Researcher, Burdwan, West Bengal, India

Email

ipsitapramanik.1995@gmail.com

City

-

Orcid

-

First Name

Malabika

Last Name

Biswas

MiddleName

-

Affiliation

Department of Microbiology, School of Tropical Medicine, Kolkata, West Bengal, India

Email

mb7081@gmail.com

City

-

Orcid

-

First Name

Shatavisa

Last Name

Mukherjee

MiddleName

-

Affiliation

Department of Clinical Pharmacology, School of Tropical Medicine, Kolkata, West Bengal, India

Email

shatavisa100@gmail.com

City

KOLKATA

Orcid

0000-0001-9524-1525

First Name

Netai

Last Name

Pramanik

MiddleName

-

Affiliation

Department of Tropical Medicine, School of Tropical Medicine, Kolkata, West Bengal, India

Email

drn90pramanik@gmail.com

City

-

Orcid

-

First Name

S

Last Name

Anuradha

MiddleName

-

Affiliation

Department of Medicine, Maulana Azad Medical College, New Delhi, India

Email

drsanuradha@gmail.com

City

-

Orcid

-

First Name

Jaya

Last Name

Chakravarty

MiddleName

-

Affiliation

Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Email

tapadar@gmail.com

City

-

Orcid

-

Volume

14

Article Issue

3

Related Issue

49910

Issue Date

2024-09-01

Receive Date

2024-04-21

Publish Date

2024-09-01

Page Start

309

Page End

314

Print ISSN

2090-7613

Online ISSN

2090-7184

Link

https://aeji.journals.ekb.eg/article_363108.html

Detail API

https://aeji.journals.ekb.eg/service?article_code=363108

Order

7

Type

Original Article

Type Code

616

Publication Type

Journal

Publication Title

Afro-Egyptian Journal of Infectious and Endemic Diseases

Publication Link

https://aeji.journals.ekb.eg/

MainTitle

Clinical and Epidemiological Profile of Mycetoma Foot: Observations from Eastern India

Details

Type

Article

Created At

24 Dec 2024